Reshema Kemps-Polanco: No ‘silver bullet’ to address health equity but Novartis making strides
Whether they recognise it or not, the entire pharma industry is involved in the business of health equity and championing it is critically important.
Whether they recognise it or not, the entire pharma industry is involved in the business of health equity and championing it is critically important.